Deutsche Bank
SBBP

Deutsche Bank’s Strongbridge Biopharma plc. SBBP Stock Holding History

Deutsche Bank’s Portfolio SBBP Stock Details SBBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-56,215
Closed -$155K – 4968
2021
Q1 		$155K Buy
56,215
+23,364
+71% +$70.5K ﹤0.01% 3772
2020
Q4 		$80K Buy
32,851
+12,815
+64% +$30.9K ﹤0.01% 3969
2020
Q3 		$42K Buy
20,036
+1,723
+9% +$5.81K ﹤0.01% 3958
2020
Q2 		$69K Buy
18,313
+7,050
+63% +$21.1K ﹤0.01% 3647
2020
Q1 		$21K Sell
11,263
-22,250
-66% -$57.8K ﹤0.01% 3907
2019
Q4 		$69K Buy
33,513
+24,411
+268% +$46.8K ﹤0.01% 3782
2019
Q3 		$21K Sell
9,102
-49,554
-84% -$133K ﹤0.01% 4311
2019
Q2 		$182K Buy
58,656
+56,712
+2,917% +$208K ﹤0.01% 3882
2019
Q1 		$9K Sell
1,944
-113,756
-98% -$560K ﹤0.01% 4957
2018
Q4 		$518K Sell
115,700
-8,910
-7% -$43.5K ﹤0.01% 3301
2018
Q3 		$605K Sell
124,610
-3,366
-3% -$17.2K ﹤0.01% 3665
2018
Q2 		$768K Buy
127,976
+63,567
+99% +$465K ﹤0.01% 3606
2018
Q1 		$568K Buy
64,409
+8,698
+16% +$65.1K ﹤0.01% 3637
2017
Q4 		$403K Buy
55,711
+36,160
+185% +$226K ﹤0.01% 3715
2017
Q3 		$133K Sell
19,551
-5,606
-22% -$38.7K ﹤0.01% 4069
2017
Q2 		$178K Buy
+25,157
New +$116K ﹤0.01% 3987
2017
Q1 		– Sell
-1,600
Closed -$3K – 5183
2016
Q4 		$3K Buy
+1,600
New +$6.52K ﹤0.01% 4796

Other funds holding SBBP

CC
Caxton Corporation Princeton, New Jersey $1.85M AUM 176.16% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Tudor Investment Corp
Tudor Investment Corp Stamford, Connecticut $53.9B AUM 29.12% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
E
Ergoteles New York $68.2M AUM 36.16% 1-Year Est. Return

Deutsche Bank's SBBP Position: Q2 2021 in Review

Deutsche Bank sold out of Strongbridge Biopharma plc. (SBBP) in Q2 2021, closing a stake of 56,215 shares — an estimated $155K sold.

Deutsche Bank first reported a position in SBBP in Q4 2016 and held it in 17 quarters. The position peaked at $768K in Q2 2018. 59 funds tracked by Wall St. Rank hold SBBP as of Q2 2021.

  • Deutsche Bank reported no remaining Strongbridge Biopharma plc. position as of Q2 2021 after selling out during the quarter.
  • Deutsche Bank sold 56,215 Strongbridge Biopharma plc. shares in Q2 2021, an estimated $155K.
  • Deutsche Bank first reported a position in Strongbridge Biopharma plc. in Q4 2016 and held it in 17 quarters.
  • Deutsche Bank's Strongbridge Biopharma plc. position peaked at $768K in Q2 2018.
  • 59 funds tracked by Wall St. Rank held Strongbridge Biopharma plc. as of Q2 2021.

Based on Deutsche Bank's 13F filing for Q2 2021, filed 11 Aug 2021.